Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | JAK1 | P23458 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14180516 | 0.84 | L3MBTL1 (0.46) | L3MBTL1KMT2AJAK2JAK1GAA | |
| SCHEMBL8979076 | 0.78 | L3MBTL1 (0.48) | L3MBTL1KMT2AJAK2JAK1GAA | |
| SCHEMBL14554355 | 0.78 | L3MBTL1 (0.48) | L3MBTL1KMT2AJAK2JAK1GAA | |
| SCHEMBL24527457 | 0.77 | L3MBTL1 (0.41) | L3MBTL1KMT2AJAK2JAK1GAA | |
| SCHEMBL22452597 | 0.76 | PTGS1 (0.43) | L3MBTL1KMT2AJAK2JAK1GAA | |
| SCHEMBL13417452 | 0.76 | GBA1 (0.55) | L3MBTL1KMT2AGAASMN1; SMN2KDM4E | |
| SCHEMBL27747166 | 0.75 | KMT2A (0.51) | L3MBTL1KMT2AGAASMN1; SMN2KDM4E | |
| SCHEMBL14438103 | 0.74 | L3MBTL1 (0.40) | L3MBTL1KMT2AJAK2JAK1GAA | |
| SCHEMBL14547837 | 0.74 | TDO2 (0.36) | KMT2AJAK2JAK1GAA | |
| SCHEMBL3216629 | 0.72 | NOS3 (0.53) | L3MBTL1GAANPSR1TSHRNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101646656-B | Pyrimidine hydrazide compounds as PGDS inhibitors | SANOFI AVENTIS SPA | 2013-08-14 | — | — | CN | claimed |
| CN-101646656-A | Pyrimidine hydrazide compounds as the PGDS inhibitor | SANOFI AVENTIS FR | 2010-02-10 | — | — | CN | claimed |
| EP-2376487-B1 | THIAZOLYL OXIME ETHER AND HYDRAZONES AS PLANT PROTECTION AGENT | BAYER IP GMBH (DE) | 2016-01-06 | — | — | EP | disclosed |
| US-9215875-B2 | Thiazolyl oxime ethers and hydrazones as crop protection agents | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-22 | — | — | US | disclosed |
| US-20140296289-A1 | Thiazolyl Oxime Ethers and Hydrazones as Crop Protection Agents | BAYER CROPSCIENCE AG (DE) | 2014-10-02 | — | — | US | disclosed |
| US-8697878-B2 | Thiazolyl oxime ethers and hydrazones as crop protection agents | BAYER CROPSCIENCE AG (DE) | 2014-04-15 | — | — | US | disclosed |
| CN-101646656-B | Pyrimidine hydrazide compounds as PGDS inhibitors | SANOFI AVENTIS SPA | 2013-08-14 | — | — | CN | disclosed |
| US-8258130-B2 | Pyrimidine hydrazide compounds as PGDS inhibitors | SANOFI (FR) | 2012-09-04 | — | — | US | disclosed |
| CN-102292334-A | Thiazolyl oxime ether and hydrazones asl plant protection agent | — | 2011-12-21 | — | — | CN | disclosed |
| US-20100190828-A1 | Thiazolyl oxime ethers and hydrazones as crop protection agents | BAYER CROPSCIENCE AG (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100048568-A1 | PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS | SANOFI-AVENTIS (FR) | 2010-02-25 | — | — | US | disclosed |
| US-6887863-B2 | Hydrazide and alkoxyamide angiogenesis inhibitors | ABBOTT LABORATORIES (US) | 2005-05-03 | — | — | US | disclosed |
| EP-1272456-B1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | ABBOTT LAB (US) | 2004-10-27 | — | — | EP | disclosed |
| US-20040167126-A1 | Hydrazide and alkoxyamide angiogenesis inhibitors | ABBVIE INC. | 2004-08-26 | — | — | US | disclosed |
| EP-1272456-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | Abbott Laboratories (US) | 2003-01-08 | — | — | EP | disclosed |
| US-20020002152-A1 | Hydrazide and alkoxyamide angiogenesis inhibitors | ABBOTT LABORATORIES | 2002-01-03 | — | — | US | disclosed |
| WO-2001079157-A1 | HYDRAZIDE AND ALKOXYAMIDE ANGIOGENESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-10-25 | — | — | WO | disclosed |
| US-5833885-A | LENSES, ULTRAVIOLET RADIATION PROTECTION | PILKINGTON PLC (GB) | 1998-11-10 | — | — | US | disclosed |
| EP-0713491-A1 | SPIRO(INDOLINO) OXAZINE PHOTOCHROMIC COMPOUNDS | PILKINGTON PLC (GB) | 1996-05-29 | — | — | EP | disclosed |
| WO-1995005385-A1 | SPIRO(INDOLINO) OXAZINE PHOTOCHROMIC COMPOUNDS | PILKINGTON PLC (GB) | 1995-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296289-A1 | Thiazolyl Oxime Ethers and Hydrazones as Crop Protection Agents | OXSR1, FOXO1, HAX1 | L3MBTL1 119/4885KMT2A 780/4885JAK2 304/4885 |
| US-20100190828-A1 | Thiazolyl oxime ethers and hydrazones as crop protection agents | OXSR1, FOXO1, HAX1 | L3MBTL1 119/4885KMT2A 780/4885JAK2 304/4885 |
| US-20040167126-A1 | Hydrazide and alkoxyamide angiogenesis inhibitors | METAP2, METAP1, ANPEP | L3MBTL1 2554/4885KMT2A 648/4885JAK2 3087/4885 |
| US-20100048568-A1 | PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS | HRH2, HRH1, HRH4 | L3MBTL1 3418/4885KMT2A 3378/4885JAK2 1345/4885 |
| US-20020002152-A1 | Hydrazide and alkoxyamide angiogenesis inhibitors | METAP2, METAP1, ANPEP | L3MBTL1 2554/4885KMT2A 648/4885JAK2 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.